Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Aslan Pharmaceuticals Ltd ADR
(NQ:
ASLN
)
0.6000
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jul 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.6000
Bid (Size)
0.5600 (8)
Ask (Size)
0.6285 (14)
Prev. Close
0.6000
Today's Range
0.6000 - 0.6000
52wk Range
0.2715 - 2.731
Shares Outstanding
402,116,835
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Top 3 Health Care Stocks Which Could Rescue Your Portfolio In July
July 18, 2024
Via
Benzinga
Dow Jumps 200 Points; Synchrony Financial Posts Upbeat Earnings
July 17, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Performance
YTD
+9.09%
+9.09%
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
+41.38%
+41.38%
1 Year
-45.45%
-45.45%
More News
Read More
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 17, 2024
Via
Benzinga
Why ASLAN Pharmaceuticals (ASLN) Shares Are Down 40%
July 17, 2024
Via
Benzinga
Crude Oil Rises 2%; Five Below Shares Plunge
July 17, 2024
Via
Benzinga
Exposures
Fossil Fuels
Nasdaq Dips 300 Points; Johnson & Johnson Earnings Top Estimates
July 17, 2024
Via
Benzinga
ASLAN Pharmaceuticals Announces it Has Filed for Voluntary Liquidation of Its Sole Operating Subsidiary and is Commencing Steps to Place Itself Into Voluntary Liquidation
July 17, 2024
From
ASLAN PHARMACEUTICALS LIMITED
Via
GlobeNewswire
Crude Oil Moves Lower; Goldman Sachs Posts Upbeat Results
July 15, 2024
Via
Benzinga
Exposures
Fossil Fuels
Why SolarEdge Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 15, 2024
Via
Benzinga
Nasdaq Surges Over 1%; Lexeo Therapeutics Shares Plummet
July 15, 2024
Via
Benzinga
Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Falls In July
July 15, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
ASLAN Pharmaceuticals Announces Receipt of Nasdaq Delisting Determination; Has Determined Not to Appeal
July 15, 2024
From
ASLAN PHARMACEUTICALS LIMITED
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
June 21, 2024
Via
Benzinga
Why Vuzix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
June 20, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
June 20, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
June 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
June 17, 2024
Via
Benzinga
ASLAN Pharmaceuticals Announces Plan to Implement ADS Ratio Change
June 14, 2024
From
ASLAN PHARMACEUTICALS LIMITED
Via
GlobeNewswire
ASLAN Pharmaceuticals Presents Late-Breaking Translational Data on Eblasakimab in COPD at the American Thoracic Society International Conference
May 21, 2024
From
ASLAN PHARMACEUTICALS LIMITED
Via
GlobeNewswire
ASLN Stock Earnings: ASLAN Pharma Beats EPS for Q1 2024
May 09, 2024
Via
InvestorPlace
ASLAN Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 09, 2024
From
ASLAN PHARMACEUTICALS LIMITED
Via
GlobeNewswire
ASLAN Pharmaceuticals to Present Additional Data From Interim Analysis of TREK-DX Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients During Virtual KOL Event
May 07, 2024
From
ASLAN PHARMACEUTICALS LIMITED
Via
GlobeNewswire
ASLAN Pharmaceuticals Announces Expansion of its Collaboration With Zenyaku to Investigate the Biology Underlying Differential Effects of Eblasakimab Compared to Other Biologics
May 02, 2024
From
ASLAN PHARMACEUTICALS LIMITED
Via
GlobeNewswire
ASLAN Pharmaceuticals to Host KOL Panel Discussion on Treatment Options for Atopic Dermatitis Patients With an Inadequate Response to Dupilumab
April 30, 2024
From
ASLAN PHARMACEUTICALS LIMITED
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
April 26, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.